RENAISSANCE TECHNOLOGIES LLC

Position in VERU — Veru Inc.

CIK 1037389 NEW YORK, NY

Position in VERU

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$514,728

+$361,686 QoQ

Shares Held

164,450

+137.5% QoQ

Ownership

0.964%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 61 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. VERU ranks #212 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$514,728	164,450	+137.5%	Shares	Sole	2026-08-13
2026-03-31	$153,042	69,250	-87.3%	Shares	Sole	2026-05-14
2023-03-31	$633,289	545,939	+550.4%	Shares	Sole	2023-05-12
2022-12-31	$443,213	83,942	-79.4%	Shares	Sole	2023-02-13
2022-09-30	$4,690,241	407,139	+125.3%	Shares	Sole	2022-11-14
2022-03-31	$872,781	180,700	+62.3%	Shares	Sole	2022-05-13
2021-12-31	$655,969	111,370	+47.1%	Shares	Sole	2022-02-11
2021-09-30	$645,857	75,716	-82.2%	Shares	Sole	2021-11-12
2021-06-30	$3,430,557	425,100	-22.2%	Shares	Sole	2021-08-13
2021-03-31	$5,888,036	546,200	+2465.0%	Shares	Sole	2021-05-13
2020-12-31	$184,193	21,294	-95.1%	Shares	Sole	2021-02-10
2020-09-30	$1,141,759	435,786	-67.6%	Shares	Sole	2020-11-13
2020-06-30	$4,487,911	1,343,686	+16.3%	Shares	Sole	2020-08-13
2020-03-31	$3,778,766	1,155,586	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.